LB

Leigh Brody

Scientist | Founder | Investor at AlbionVC

London, England

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $5,000,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $7,000,000.00

Skills

Cell Biology
Molecular Biology
Biochemistry
Cell Culture
Confocal Microscopy
Bioinformatics
qPCR
Genetics
Biotechnology
Genomics
Tissue Culture
Life Sciences
Western Blotting
Science
Fluorescence Microscopy
Scientific Writing
In Vivo
PCR
Clinical Research
Lifesciences

Education

Lists including Leigh

AP
AO
AS
AN

Based in UK

1884 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

A
AlbionVC

2021

  • Investment Manager, UCL Technology Fund

    2021

    The UCL Technology Fund is managed by AlbionVC and is dedicated to investing in the next generation of life-changing innovative technologies, arising from UCL's world-class research base.

BG
Bloomsbury Genetic Therapies

2022

  • Board Director

    2022

AA
Alma Angels

2022

  • Member and Angel Investor

    2022

QT
Quell Therapeutics

2019 - 2020

  • Executive Director of Platform Strategy

    2019 - 2020

DG
Desktop Genetics

2015 - 2019

  • Chief Scientific Officer

    2015 - 2019

GlobalAcorn (Advanced Therapeutics)

2012 - 2014

  • Founder

    2012 - 2014

    Founder of a spin-out from my PhD, developing lipid-based nanoparticles (LNPs) for small molecule and mRNA delivery solutions.

IV
Index Ventures

2013 - 2014

  • Life Science Investor

    2013 - 2014

TB
The Broad Institute of Harvard and MIT

2005 - 2008

  • Research Scientist

    2005 - 2008

    The RNAi Consortium (TRC) - TRC1, 1.5, 2 and Project Achilles.